CELLSEED

cellseed-logo

CellSeed develops regenerative medicine products primarily in Japan and Europe. The company offers regenerative medicines such as epithelial cell sheet for corneal and esophageal regeneration, regenerated cardiac patch to treat heart diseases, cell sheet for periodontal tissue regeneration, and regenerated cartilage sheet for the treatment of osteoarthritis The company was founded in 2001 and is headquartered in Tokyo, Japan.

#People #Financial #Website #More

CELLSEED

Social Links:

Industry:
Alternative Medicine Health Care Market Research

Founded:
2001-05-01

Address:
Tokyo, Tokyo, Japan

Country:
Japan

Website Url:
http://www.cellseed.com

Total Employee:
11+

Status:
Closed

Total Funding:
3.17 B JPY

Technology used in webpage:
LetsEncrypt Euro Japanese Yen Apple Whitelist GlobalSign AlphaSSL SAKURA Internet GMO Internet


Current Employees Featured

not_available_image

Yukio Hasegawa
Yukio Hasegawa Owner @ CellSeed
Owner

Founder


not_available_image

Yukio Hasegawa

Stock Details


Company's stock symbol is TYO:7776

Investors List

whiz-partners_image

Whiz Partners

Whiz Partners investment in Post-IPO Equity - CellSeed

dai-nippon-printing_image

Dai Nippon Printing

Dai Nippon Printing investment in Venture Round - CellSeed

mitsubishi-ufj-capital_image

Mitsubishi UFJ Capital

Mitsubishi UFJ Capital investment in Venture Round - CellSeed

fast-track-initiative_image

Fast Track Initiative, Inc.

Fast Track Initiative, Inc. investment in Venture Round - CellSeed

mitsubishi-ufj-capital_image

Mitsubishi UFJ Capital

Mitsubishi UFJ Capital investment in Venture Round - CellSeed

smbc-venture-capital_image

SMBC Venture Capital

SMBC Venture Capital investment in Venture Round - CellSeed

nomura-securities_image

Nomura Holdings

Nomura Holdings investment in Venture Round - CellSeed

shoko-chukin-bank_image

Shoko Chukin Bank

Shoko Chukin Bank investment in Venture Round - CellSeed

nippon-venture-capital_image

Nippon Venture Capital

Nippon Venture Capital investment in Venture Round - CellSeed

ant-capital-ltd_image

Ant Capital Partners

Ant Capital Partners investment in Venture Round - CellSeed

Official Site Inspections

http://www.cellseed.com

  • Host name: 157.87.49.163.rev.iijgio.jp
  • IP address: 163.49.87.157
  • Location: Japan
  • Latitude: 35.69
  • Longitude: 139.69
  • Timezone: Asia/Tokyo

Loading ...

More informations about "CellSeed"

CellSeed Inc. - Regenerate the future

CellSeed is based on an innovative regenerative medicine technology called cell sheet engineering, which originated in Japan. Based on this technology, we are developing a variety …See details»

Corporate Information|CellSeed Inc. - Regenerate the future

Feb 5, 2010 CellSeed Inc. Main Business: Cell sheet regenerative medicine; Intelligent cell cultureware products; Head office: 15F (East Wing) Telecom Center Building 2-5-10, Aomi, …See details»

CellSeed - Crunchbase Company Profile & Funding

CellSeed develops regenerative medicine products primarily in Japan and Europe. The company offers regenerative medicines such as epithelial cell sheet for corneal and esophageal …See details»

CellSeed - 株式会社セルシード

2025年定時株主総会招集通知 「第24期定時株主総会招集ご通知」の株主総会参考書類をご検討のうえ、郵送またはインターネットによる方法で 2025年3月24日(月)午後5時30分 までに …See details»

CellSeed Inc. (7776.T) Company Profile & Facts - Yahoo Finance

See the company profile for CellSeed Inc. (7776.T) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»

Company Profile -CellSeed Inc.- - YouTube

Jun 4, 2024 CellSeed has been consistent in conducting research and development to deliver regenerative medicine based on cell sheet engineering to patients. We will con...See details»

CellSeed - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors ... Jan 16, 2009: Venture Round - CellSeed . 3: obfuscated. …See details»

CellSeed Inc. (TYO:7776) Company Profile & Overview - Stock …

Jan 31, 2025 CellSeed Company Description CellSeed Inc. develops cell sheet regenerative medicines. It is involved in the research, development, and commercialization of cell-sheet …See details»

CellSeed Company Profile - Office Locations, Competitors ... - Craft

CellSeed has 4 employees at their 1 location and ¥190.13 m in annual revenue in FY 2023. See insights on CellSeed including office locations, competitors, revenue, financials, executives, …See details»

CellSeed 2025 Company Profile: Stock Performance & Earnings

CellSeed General Information Description. CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet …See details»

About CellSeed | CellSeed Inc. - Regenerate the future

CellSeed's Business Model. Regenerative medicine is a new type of medicine that regenerates and treats lost, damaged, or dysfunctional organs. CellSeed aims to contribute to medical …See details»

CellSeed Company Profile | Management and Employees List

Find contact information for CellSeed. Learn about their Business Services market share, competitors, and CellSeed's email format.See details»

About CellSeed Inc (7776) - Investing.com

CellSeed Inc. develops cell sheet regenerative medicines. It is involved in the research, development, and commercialization of cell-sheet regenerative medicine products, such as …See details»

CellSeed, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore CellSeed, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, and 13 literature, Technology Platform:Cell therapy, Biological products, Drug:CLS2901C, …See details»

CellSeed, Inc. Company Profile & Data: stocks, market cap, …

Jan 1, 2025 CellSeed Inc. develops regenerative medicine products primarily in Japan and internationally. It is involved in the research, development, and commercialization of cell-sheet …See details»

CellSeed - Products, Competitors, Financials, Employees, …

CellSeed Inc 7776 Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, …See details»

株主・投資家情報|細胞シートの再生医療技術 - セルシード

セルシードの株主・投資家情報です。セルシードは、細胞シート工学という日本発の革新的再生医療技術を基盤としております。細胞シートを再生医療製品として事業化することで、医療 …See details»

CellSeed - Company Profile - Tracxn

Jan 3, 2025 CellSeed - cell culture consumable. Public Company. Raised a total funding of $6.99M over 2 rounds from 14 investors. CellSeed has 2739 competitors.See details»

CellSeed - Contacts, Employees, Board Members, Advisors & Alumni

CellSeed is a biotechnology company that produces a number of cell sheet regenerative medicine products, including cell culture equipment. New. Resources. Advanced Search. Start Free …See details»

What's regenerative medicine - CellSeed Inc.

Regenerative medicine products approved in Japan. In Japan, as of November 2024, 19 items of regenerative medicine products have been approved. 6 items are tissue transplants, 5 items …See details»

linkstock.net © 2022. All rights reserved